Englewood Hospital and Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Englewood Hospital and Medical Center sits in the top decile of US sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count).
Englewood Hospital and Medical Center: 18 sponsored US clinical trials, 4 recruiting.
Englewood Hospital and Medical Center sponsors 18 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 8 completed. 1 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Liver Regeneration, with 1 trials.
Top-decile sponsor footprint
Englewood Hospital and Medical Center ranks in the top decile of sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
8 of 13 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (61.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
18 total, page 1 of 1
Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
NCT06681818
Pilot Study Evaluating the Advantages of Sucrosomial® Iron Post-operative Supplementation vs Standard of Care After Cardiac Surgery
NCT06970925
Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-
NCT06937996
Fecal Microbiota Transplantation for C Diff Infection
NCT01905709
Pilot Study of MammoGRIP for Breast Positioning, Image Quality, and Patient Comfort in Mammography
NCT07388940
Minimally Invasive Treatment of Primary Great Saphenous Vein (GSV) Insufficiency Using High Intensity Focused Ultrasound (HIFU)
NCT05193643
A Randomized Controlled Trial to Evaluate the Efficacy of Acupuncture Versus Aromatherapy as Treatments to Lessen Nausea, Vomiting and Anxiety Associated With Adriamycin and Cytoxan
NCT04116697
A Study to Evaluate the Use of the Neotech RAM Nasal Cannula for CPAP and Bi-PAP Application in Infants 28-42 Weeks Gestation in a Neonatal Intensive Care Unit (NICU)
NCT04096235
Weighted Pacifier Vs. Non-Weighted Pacifier
NCT04095702
Does Melatonin Affect Anesthetic MAC (Minimum Alveolar Concentration)?
NCT03241004
Cooling Vest in Men With Hot Flashes
NCT03000322
Negative Pressure Therapy for Groin Wounds
NCT02954835
Study to Evaluate the Effects of the Cooling Bolero in Women With Common Menopause Symptoms
NCT02795741
Microneedling Plus the Universal Peel For Acne Scarring
NCT02174393
Electrophysiologic Mapping of the Bladder
NCT02041442
BIS-Guided Sedation Monitoring
NCT02045927
Paclitaxel for the Treatment of Upper-Extremity Arteriovenous Access Fistula Stenosis
NCT01868984
Utility of the Audible Alert in Current Generation Medtronic Implantable Cardioverter-defibrillators
NCT01605500
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 4 | 1 |
Therapeutic Areas
What is open in the Englewood Hospital and Medical Center pipeline
4 recruiting of 18 indexed (22% open); 8 completed (44%).
Phase mix: 1 late (III/IV) vs 2 early (I/II) (early-phase heavy).
Top condition: Liver Regeneration (1 trial), 4 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Englewood Hospital and Medical Center: open-pipeline peers nationwide
Peers matched on 18 registered trials and 22% open enrollment, not the therapeutic-area sidebar.
Englewood Hospital and Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 18 trials (± recruiting share)
- ADC Therapeutics S.A. · 18 trials · 11% recruiting
- Akros Pharma · 18 trials · 0% recruiting
- AO Clinical Investigation and Publishing Documentation · 18 trials · 0% recruiting
- AO Innovation Translation Center · 18 trials · 33% recruiting
Sponsors near 22% open enrollment (± trial volume)
- ALX Oncology · 22% recruiting · 9 trials
- Biosense Webster · 22% recruiting · 18 trials
- Ensysce Biosciences · 22% recruiting · 9 trials
- Harvard University Faculty of Medicine · 22% recruiting · 9 trials
Related
What to do with this Englewood Hospital and Medical Center page
18 registered trials is a research-attention snapshot, not an endorsement of Englewood Hospital and Medical Center or any single study.
- 4 of Englewood Hospital and Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Liver Regeneration is the condition Englewood Hospital and Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Liver Regeneration trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Englewood Hospital and Medical Center pipeline card: 18 registered trials from official public datasets.Report a data error.